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Abstract 
Background: There is a need for primary care interventions for patients with multiple medically 
unexplained symptoms (MUS). We examined whether GPs could be taught to deliver one such 
intervention, the Symptoms Clinic Intervention (SCI), to patients. The intervention includes 
recognition and validation of patients’ symptoms, explanation of symptoms and actions to manage 
symptoms. 
Methods: We conducted an uncontrolled observational study in North East Scotland. GPs were 
recruited and received two days of structured training. Patients were identified via a two stage 
process (database searching followed by postal questionnaire) and received the SCI intervention 
from a GP in their practice. 
Treatment fidelity was assessed by applying a coding framework to consultation transcripts. Safety 
was assessed by examining changes in patient symptom (PHQ-15) and checking for unexpected 
events. Acceptability was primarily assessed by patient interview. 
Results: Four GPs delivered the SCI to 23 patients. GPs delivered all core components of the SCI, and 
used the components flexibly across the consultations and between patients. They spent more time 
on recognition than either explanation or actions components. 10 out of 17 patients interviewed 
described feeling validated, receiving useful explanation and learning actions.  9 out of 20 patients 
(45%) reported an improvement in PHQ-15 of between 3 and 8 points. Patients who reported the 
most improvement also described receiving all three components of the intervention.  
Conclusions: GPs can be taught to deliver the SCI with reasonable fidelity, safety and acceptability, 
although some items were inconsistently delivered: further training would be needed before use. 
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Introduction 
Persistent physical symptoms which cannot be adequately explained by organic disease, so-called 
medically unexplained symptoms (MUS), are a common and important cause of ill health and 
healthcare use. MUS are extremely common in patients attending general practitioners [1]. While 
the majority of symptoms are self-limiting and mild, approximately 2% of adults experience repeated 
and persistent MUS which are associated with impaired quality of life [2] and increased healthcare 
demand [3] which many doctors have limited skills to address [4]. 
Despite the title, most MUS can be adequately explained in terms of biological and psychological 
processes. Several models have been proposed with recent interest focusing on the neurobiological 
model of central sensitisation [5]. Processes of symptom generation may be affected by past or 
recent emotional events and by tendencies to worry about or be demoralised by symptoms. A 
number of classifications have been proposed for multiple MUS though none is in widespread use 
outside of specialist practice. The most recent, DSM-5 Somatic ymptom Disorder [6] includes the 
experience of multiple symptoms, and while it no longer requires that symptoms are unexplained by 
disease, it does stipulate that they must be accompanied by excessive concern, worry or help-
seeking. 
While there is evidence for modest effectiveness of psychological interventions for MUS in specialist 
settings[7], there is currently no strong evidence for effectiveness of treatment for patients with 
multiple MUS in primary care. Our earlier Cochrane systematic review found no benefit from very 
brief interventions but raised the possibility that moderately intensive interventions – approximately 
two hours of consultation time might have value [8]. We recently developed the Symptoms Clinic 
Intervention (SCI) – a GP with Special Interest intervention for patients with multiple physical 
symptoms – as a moderate intensity intervention to be delivered by a specially trained primary care 
physician [9].  
The SCI is based on the premise that patients with symptoms value the following: being listened to 
and understood; constructive explanations which make sense of their symptoms; and support in 
living with their symptoms [10-12].  It builds on the reattribution model [13] in three ways – by using 
more time (similar to other moderate intensity interventions [14]), by expanding the language of 
explanations for symptoms, specifically avoiding simple psychosomatic causal links [4,15,16], and by 
emphasising management of symptoms as problems in their own right with direct impacts on quality 
of life.  
 An earlier pilot trial had indicated potential benefit from the SCI [9]. We conducted this study as 
step on the route to a definitive evaluation of the SCI in a randomised controlled trial. In it we aimed 
to teach the SCI to a new group of GPs, then evaluate their delivery of this intervention to patients 
under observation. In reporting the study we have selected the outputs for reporting according to 
the IDEAL [17] model for intervention development (in this case the study could be considered 
primarily as stage 2a Development). As such, the emphasis in this manuscript is on the delivery of 
the intervention and the outcomes focus on procedural fidelity, safety, and basic acceptability to 
patients. This study did not aim to generate generalisable data about efficacy. 
In this report we concentrate on three questions: (1) Did GPs deliver the intervention with sufficient 
fidelity? (2) Was delivery “safe” i.e. were short term outcomes in the direction expected with no 
unintended consequences? (3) Was the intervention acceptable to patients in terms of satisfaction 
and absence of complaint?  
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Methods 
Study Design 
This was an observational study designed to assess whether, after training, GPs could deliver the 
Symptoms Clinic Intervention to patients with multiple medically unexplained symptoms in their 
practices.  
Symptoms Clinic Intervention  
The SCI comprises a structured series of three or four consultations over a period of approximately 
six-eight weeks by a GP. The SCI is comprised of four key elements: Recognition, Explanation, Action 
and Learning. The first consultation lasts around 50 minutes and focuses on Recognition, which 
centres on eliciting and actively listening to the patient’s description of their illness and its 
consequences on daily living. Successful recognition aims to validate the individual, may have 
“healing potential” in itself [18] and is important for improving symptom appraisal and active coping 
behaviour. In the latter part of this first consultation, and in the subsequent shorter (15-20 minute) 
consultations, there is a focus on negotiating Explanations for symptoms in terms of biological and 
psychological mechanisms [15] and adaptations and proposing Action in terms of symptom control 
and management techniques which are coherently linked to the explanation. Throughout the 
consultations the doctor and patient reflect and Learn what makes sense and is helpful. A range of 
consultation techniques linked to these components were presented at the training days and were 
detailed in a training manual (available on request from corresponding author) that all GPs received; 
GPs were encouraged to use those techniques that they thought appropriate on a case by case basis.  
 
Study Participants 
GPs 
We recruited GPs from Northeast Scotland by mail, followed by personal contact from the research 
team. Initial training was conducted in a group setting over two days and comprised a mixture of 
didactic teaching, discussion and role play.  The training sessions were led by the study investigators 
and were designed to provide GPs with information about symptoms and the experience of multiple 
(“medically unexplained”) symptoms and practical training on the key components of the SCI 
(detailed above). Participating GPs also received two sessions of follow up training, delivered on a 
one-to-one basis. These follow-up sessions were designed to allow GPs to raise any concerns related 
to their delivery of the intervention or about particular patients during the course of the study.  
Patients 
We used the same practice database search strategy as the pilot trial of the SCI [9]to systematically 
identify adults aged 18 or over with multiple symptoms using a combination of diagnostic and 
referral criteria. The criteria were (a) at least one diagnostic code indicative of a functional somatic 
syndrome (e.g. tension headache, chronic fatigue syndrome, irritable bowel syndrome) in the 
electronic record; (b) at least two referrals for diagnostic investigation or specialist opinion in the 
preceding three years. These criteria were developed following an epidemiological study which 
showed that patients with repeated referrals and MUS had significantly impaired quality of life and 
increased healthcare costs [2,19]. As practice searches were conducted after recruitment and 
training of the GPs, we needed to relax the patient criteria in two practices in order to invite 
sufficient patients. In one practice, few syndrome diagnoses were coded: we therefore included 
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patients meeting the referral criteria and with functional syndrome diagnoses recorded elsewhere in 
the records. In the other (a rural practice), coded diagnoses were present but the GPs reported 
actively seeing patients for extra appointments rather than referring: we permitted patients to be 
included who did not meet the specialist referral criteria.  Within each practice, patients were 
sequentially invited in batches until 6 patients for that practice had been recruited or all potential 
patients had been invited.  
Participating GPs screened the list of identified patients to exclude patients in whom symptoms 
were likely to be due to, or confounded by, other conditions (e.g. cancer, diabetes, rheumatoid 
arthritis); who required significant assistance with daily living (as such patients were likely to require 
more intensive treatment than that provided); were currently undergoing active multidisciplinary 
rehabilitation or psychological treatment; or for whom participation would be inappropriate (e.g. 
recent bereavement or complaint about treatment). Remaining patients were sent an invitation 
letter from the practice with information about the study, the Patient Heath Questionnaire-15 
(PHQ15) [20] which was used as a screening measure, and a reply form. Respondents whose PHQ15 
was ≥10 (indicative of at least moderate MUS), were contacted by phone to discuss the study further 
and to again check the exclusion criteria (see above). Those who met the inclusion criteria and who 
were interested in taking part in the study completed enrolment.  This consisted of giving written 
informed consent and self-completion of baseline outcome measures immediately before their first 
SCI consultation. 
Data Collection 
Qualitative data 
GPs audio-recorded the SCI consultations for subsequent analysis. Patients were also asked to 
participate in a brief follow-up interview approximately two weeks after their final SCI appointment. 
This semi-structured interview explored patients’ perceptions of the consultations, the explanations 
discussed for their symptoms, and the actions negotiated to reduce the impact of symptoms on daily 
living. These interviews were carried out over the telephone by a member of the research team, 
audio-recorded and transcribed.  
Outcome measures 
Patients completed the PHQ-15, PHQ-9 measure of depressive symptoms [21], GAD-7 [22] measure 
of anxiety and EQ-5D-5L [23] questionnaires at baseline and again approximately two weeks after 
their final appointment (6-10 weeks after baseline for patients having 3-4 appointments). The final 
questionnaire pack was returned by post to the research team.  The PHQ-15, PHQ-9 and GAD-7 were 
chosen to permit comparison between this study and the pilot trial.  Additionally, patients 
completed a 7-point Patients’ Global Impression of Change measure (PGIC), as well as a Client 
Satisfaction Questionnaire (CSQ) at follow-up.  
Data analysis 
Fidelity of intervention delivery 
We classified consultation content using a checklist in order to examine whether the trained GPs 
delivered the key components of the SCI. We developed the content checklist by thematically coding 
the consultation transcripts from the previous pilot trial. The content checklist comprised detailed 
codes grouped into Recognition, Explanation, and Action clusters, representing three parts of our 
underlying model. The fourth part of the model, Learning, was always linked to either Explanation or 
Action so was not coded separately. An additional Other cluster was used for coding non-core 
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components of the intervention (e.g. social chit-chat, description of the study, etc.). Table 1 lists the 
specific content items by category. 
For each consultation we measured time spent on each content item.  As codes sometimes 
overlapped or ran in parallel, we listed all codes occurring in each 5 minute segment of the 
consultation and divided the time equally between them, rather than try to partition time more 
specifically. 
Safety of delivery 
The purpose of this study was not to statistically compare outcomes with other studies but to check 
that the direction of change was as anticipated. For PHQ-15, EQ-5D, PHQ-9 and GAD-7 we calculated 
means and standard deviations at baseline and follow-up. We examined the transcripts of 
consultations and interviews for evidence of patients reporting unexpected events or unintended 
consequences. In the previous pilot trial, the mean reduction in PHQ-15 was 3.2 points. While there 
are no published minimally clinically important differences for this measure, in the pilot trial a 
change of 3 or more points was associated with an improvement of between one and two levels on 
the Patient Global Impression of Change suggesting that this change is likely to be clinically 
meaningful. 
Acceptability of the Intervention 
We analysed the content of the follow-up interviews using a framework approach focusing on three 
components: recognition - whether patients felt listened to and validated, whether patients received 
useful explanation of their symptoms, and whether they had learned new actions to manage 
symptoms (or reinforced existing ones). Two investigators repeatedly read the transcripts and 
discussed features which indicated whether these had been achieved or not. Both then 
independently graded each interview to assess the presence or absence of each of the three 
components and resolved differences by discussion. We also assessed the number of patients who 
rated the intervention positively and negatively on the CSQ. 
  
Results 
Recruitment & Participation 
We approached 76 practices.  Eleven GPs from nine practices expressed initial interest. Five of these 
GPs were able to schedule their work to allow them to take part in the study and complete the 
training. Two GPs withdrew from the study following training due to changes in personal 
circumstances and a sixth was recruited, giving a total of four GP participants. Three of the four GPs 
who delivered the intervention to patients in their practices were female and had more than 15 
years’ experience of general practice. The remaining, male, GP had less than 5 years post-training 
experience. Practices ranged in size from 5574 to 16814 registered patients and were in rural / semi-
rural towns in Northeast Scotland. Although GPs saw patients from their own group practice, the 
intervention was not typically delivered in the context of a long-term GP-patient relationship: only 
one patient regarded the trained GP as a familiar doctor. 
We aimed for GPs to deliver the intervention to six patients in their practices; this sample size was 
chosen to demonstrate fidelity to the SCI. The searches identified a total of 180 patients (21-89 per 
practice), 11 of whom were excluded by the participating GPs prior to invitation. In practices with 
low rates of coding or referrals, GPs identified seven additional patients who met entry criteria. Of 
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the 176 potential patients, 137 were invited from the four practices, of whom 59 returned the 
expression of interest form and PHQ-15 screening measure (43%). Forty-four of these patients were 
eligible based on their PHQ-15 score (75% of interested patients). We scheduled enrolment 
appointments with 24 patients on a first come basis; however, one did not attend their appointment 
and 23 patients therefore enrolled in the study. All enrolled patients attended their first SCI 
appointment and 18 (78%) received three or four appointments in total. This is shown in detail in 
Figure 1. 
Patient Characteristics 
Patient ages ranged between 24 and 78 (mean = 51.3, standard deviation 12.7) and 21 (91%) were 
female. Eleven were currently employed, 5 were retired, 3 were unemployed or unable to work, 3 
were at home and one was a student. Main reported limiting symptoms (up to 2 per patient, 
grouped according to recently proposed categories [24]) were general (fatigue, dizziness, headache 
etc.) 15; musculoskeletal, 14; gastro-intestinal, 6; cardiopulmonary, 4; mental (depression, stress), 3 
and not specified, 4.  
Patients’ baseline measures are shown in Table 2. Eleven patients had PHQ-15 scores indicative of 
medium somatic symptom severity (score of 10-14) at baseline, while 12 patients had a score 
indicative of high somatic symptom severity (score ≥15). Based on baseline GAD-7 and PHQ-9 scores, 
over half of patients (n=14) had mild to severe anxiety, 11 patients had mild-moderate depressive 
symptoms and five had more severe depressive symptoms. Medical case notes were not reviewed 
and we did not attempt to determine whether these patients had formal clinical diagnoses of 
anxiety or depression. 
Intervention Fidelity 
Figure 2 illustrates the average time per patient that was allocated to the components of the 
intervention, separated by initial consultation and total subsequent follow-up consultations. As 
expected, the majority of the initial consultation was spent on Recognition, with little explanation or 
symptom management. Two of the GPs chose to use the entirety of the first consultation to listen to 
the patients’ accounts of their illnesses and build rapport, and did not bring Explanation or Action 
into the first consultation. In the follow up consultations, GPs spent more time on the Explanation 
and Action components, including suggesting and reviewing symptom control strategies. Although 
the manual included techniques for challenging unhelpful beliefs about symptoms, GPs used these 
infrequently.  
Intervention Safety – Outcome measures 
We collected outcome measures for 20 (87%) patients. This data is summarised in Table 2. Despite 
postal and telephone reminders, we were unable to collect follow-up questionnaires for the 
remaining three patients. 14 out of the 20 patients reported at least one level of improvement out 
of seven on the Patient Global Impression of Change measure.  
The mean PHQ15 change was broadly equivalent to those reported in the pilot trial, however there 
was considerable variation between individuals (range -8 to +6 (negative scores indicate 
improvement): 5 patients reporting an improvement of 6 or more points and 4 of 3-4 points. 5 
patients reported no change; the one worse score was the same as at initial screening, but higher 
than at entry.  The three patients with very high baseline scores (≥20) showed no change in PHQ15.  
We found no major unexpected changes in physical or mental health. One patient developed 
worsening sciatica on a background of non-specific back pain and was referred to a spinal surgeon, 
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another developed new, possibly cardiac, symptoms and was referred to a cardiologist. In both cases 
there was nothing from the consultation transcripts to suggest serious medical conditions were 
overlooked,  
Intervention Acceptability -  patient interviews & satisfaction 
We held follow-up interviews with 17 (74%) patients. Table 3 contains example quotes relating to 
recognition, explanation, and symptom management with short interpretive comments. Recognition 
included not just the GP listening more, but being perceived as understanding the patient better. 
Explanations were described as being accepted as new information which was required to be 
integrated with existing knowledge and experience. No patient described explanations in terms of 
transforming their knowledge and some challenged or rejected explanations in contests of authority 
[25]. Relatively few patients described GPs suggesting ways of managing symptoms beyond simple 
pacing or graded activity, although some described learning and adopting new symptoms 
management strategies. In two cases, recommendations for graded activity and simple pacing were 
interpreted as un-original, unrealistic, or as implying laziness. 
 
From the interviews we assessed 13 patients as reporting recognition and 4 not. Of those reporting 
recognition, explanation was clearly or implicitly described by 10. All the patients with PHQ-15 
improvements of 6 or more points and for whom there was an interview described all three of 
recognition, explanation and symptom management at interview.   
  
Patients rated the SCI positively on the CSQ. All 20 patients who completed the CSQ rated the care 
they received as good or excellent; 4 indicated that it had not helped them to deal with their 
problems more effectively. 
 
 
Discussion 
Summary of Main findings 
The training resulted in GPs being able to deliver the SCI with reasonable fidelity, although there was 
room for improvement in explanation and action components. 10 out of 17 interviewed patients 
perceived the intervention as delivering all three core components and 9 out of 20 reported an 
improvement in PHQ-15 of between 3 and 8 points. The study found no safety concerns with the 
intervention, which was acceptable to the majority of participants. This demonstrates that the SCI 
can be delivered, but that future training will need to be longer than 2 days and include more work, 
especially on explanation and action components.  
Strengths and limitations 
This study used a previously developed pathway for identifying potential participants and this 
resulted in the intervention being delivered to patients who had multiple MUS with moderate to 
moderately severe symptoms (most patients had a PHQ15 score between 10 and 20).  None of the 
GPs trained in this study had prior experience of interventions for MUS.  
The issue of fidelity to treatment is important in delivering consultation interventions but is 
challenged by the heterogeneity of patients with multiple MUS which is seen in practice and the 
array of possible components within the SCI. Careful classification, and timing of the use of, 
intervention components meant that we were able to map use of key components, even when the 
exact content varied to match the individual patients. The allocation of components to 5 minute 
blocks of time introduced some imprecision, but it permitted sections of consultations where several 
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components overlapped to be coded simply; given the overall length of the intervention, minor 
details on timing are unlikely to have been important. The tools for mapping content can be used in 
future studies of the SCI to ensure fidelity to the overall model. 
We found some deviation from the intended SCI model in that some doctors used the whole first 
consultation for information gathering and rapport building rather than proposing explanations. 
While this may have slightly reduced the potential for benefit, their patients kept subsequent 
appointments. In contrast, one GP often moved quite quickly to proposing explanation and action 
within the first consultation and this appeared to be associated with lower satisfaction, less 
adherence to follow up and less improvement in symptoms at follow up. Two potential concerns 
with the delivery of the intervention in this study are that, unlike CBT, there was relatively little 
challenging of patient beliefs and there were relatively few examples at interview of actions which 
patients had taken and put into practice. Given the importance of challenge or exposure during 
treatment and of consolidating behaviour change, these aspects will require additional focus in 
future intervention development and training. 
The study raises a number of issues regarding future trials and generalisability of this intervention. 
Firstly the lack of change in PHQ-15 in all three patients whose baseline value was above 20 suggests 
an upper threshold of severity for this moderate intensity intervention. Secondly in this study only 2 
(9%) were male. Data from other studies suggest that approximately 35% of the target population 
are male [2] so this raises questions about identification or acceptability. However, in our previous 
study of the same intervention [9] 11/32 (34%) participants were male so we suspect that the low 
level of participation in males in this study was the result of either local contextual factors or 
differences in coding by GP practices which influenced the search strategy. Overall 37/137 (27%) 
invited patients were eligible and willing to participate (although places were only available for 23), 
which we regard as sufficient to indicate that if the intervention was available and recommended in 
routine practice it would be generalisable. 
We were limited by circumstances of practice size and time, a relatively small number of patients, 
and to short follow up. As expected, the yield of computer searches, and with it the number of 
potentially eligible patients, varied between practices. In a trial, the effects of such uncontrollable 
variation would be limited by randomisation of individual patients within practices, however this was 
not a controlled study and so is not suitable for making generalisable conclusions about outcomes. 
As we were committed to recruiting patients from the GPs’ own practices for this study we needed 
to relax the entry criteria around coded diagnoses and referrals but would avoid this in a definitive 
trial.  
Relationship to other research 
The SCI is a moderately intensive intervention and as such is similar to the extended treatment 
model described in two European trials [14,26] but very different from attempting treatment within 
the constraints of routine 10 minute consultations. In many ways the intervention was similar to the 
enhanced medical consultation model used as a control intervention in a recent trial of 
psychodynamic interpersonal therapy[27], however the SCI also includes specific explanation 
components which are not present in other interventions; unlike the enhanced medical consultation 
the SCI appears to have a clinically meaningful effect on reported symptoms (mean change in PHQ15 
of 3 points for SCI compared to <1 for enhanced medical consultation).  
Support for the importance of explanation comes from a recent review of the effects of emotional 
and cognitive reassurance in primary care studies [28], which showed that to be effective 
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reassurance must contain cognitive components – such as explanation. One other treatment model 
has emphasised explanations [29]. However this used a limited repertoire of explanations in relation 
to stress and stress hormones – whereby emotional distress was experienced as physical symptoms 
mediated through stress biology [30]. In contrast, the SCI does not require emotional distress for 
causation, rather it permits it to be included as a consequence, cause or mediator- or even left out 
completely if the patient wishes – without invalidating the model. We believe that the high rates of 
acceptance of explanations and willingness to move on to symptom control indicate the 
acceptability of the explanations within the SCI. 
Implications for practice, policy and research 
GPs currently lack the confidence and skills to manage medically unexplained symptoms effectively 
[4] and specialist services rarely achieve more than temporary reassurance for patients by excluding 
disease [31]. Additionally, previously developed brief approaches for GPs within ordinary 
consultations, have been found to be ineffective [8]. The Symptoms Clinic Intervention is a 
constructive and generalisable alternative which has the potential to substantially reduce patients’ 
symptoms and their impact on daily living and subsequently on healthcare use.  Studies are now 
needed to test its medium to long term effectiveness in reducing symptoms and to examine the 
potential for savings due to reduced demand for disease centred diagnostic investigations and 
treatments. 
Conclusion 
The Symptoms Clinic Intervention is a promising intermediate care intervention for patients with 
multiple medically unexplained symptoms / somatic symptom disorder. GPs can be taught to deliver 
it with reasonable fidelity, safety and acceptability; further training would will need to be longer 
than that used here and focus more on symptom explanation and management.  
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Table 1, Symptom Clinic Intervention (SCI) component categories and items used to check content of 
audio-recorded SCI consultations 
Category  Item description  
Recognition 1. Active listening to patient's account  
Doctor hears, seeks to 
understand and validates 
patient experience.  
Doctor recognises symptoms 
as within area of authority. 
2. Elicits / discusses patient's perspective of their health/symptoms 
3. Elicits / discusses patient's mental state (past or present) or coping style 
4. Elicits / discusses impact of symptoms on daily life & activities 
5. Elicits / discusses impact of symptoms on social and emotional aspects of 
life 
6. Elicits / discusses thoughts and feelings about previous tests and 
treatment 
7. Elicits / discusses patient's ideas on symptom triggers/patterns/warning 
signs 
  
Explanationa 1. Proposing and negotiating 1st explanation 
Doctor explains symptoms in 
terms of adaptive or other 
processes. 
2. Proposing and negotiating 2nd explanation 
3. Proposing and negotiating 3rd or more explanation 
4. Checks how explanation is received 
  
Action 1. Elicits information about current action to manage symptoms / impact 
Doctor proposes and 
negotiates symptom 
management strategies. 
2. Proposes new action to manage symptoms / impact 
3. Negotiates new specific tasks relating to lessening impact of symptoms 
4. Reviews actions to manage symptoms / impact 
5. Challenges thoughts / attitudes / beliefs / diagnostic labels 
Learning  
Doctor & patient reflect on use 
of explanation and action in 
practice.  
Reliable discrete codes for this were difficult to develop. Learning appeared 
as part of both explanation and action and is included in item 4 of each of 
these.  
a Explanation items do not include detailed explanation content as this was coded using a separate 
explanation taxonomy  
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Figure 1, Recruitment and retention of patients from participating practices  
 
78 patients did not reply 
15 patients excluded: <10 PHQ15  
- 2 patients unavailable 
- 3 patients ineligible  
- 2 patients unable to contact  
- 14 patients notified that no further 
places          were available 
 
R
ec
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m
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t 
137 patients invited 
59 patients returned initial 
consent form and PHQ15 
23 patients enrolled 
44 patients expressed interest 
and scored ≥10 on PHQ15 
3 patients did not return follow up 
questionnaires 
SC
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1 patient unable to contact further 
-1 patient no longer suitable to 
participate (surgery proposed) 
-1 patient unable to contact further 
-2 patients declined further 
participation 
-9 patients deemed by GPs to not 
require 4th appointment 
-1 patient no longer suitable to 
participate (ongoing cardiac 
investigations) 
22 patients attended 2nd SCI 
appointment 
18 patients attended 3rd SCI 
appointment 
8 patients attended 4th SCI 
appointment 
20 patients completed follow 
up questionnaires 
180 patients from computer 
search +7 from hand search 
 - 11 patients excluded by GP 
 - 39 patients not invited to avoid over-
recruitment 
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Table 2 Baseline measures for all enrolled patients; baseline and follow up measures for those who 
completed outcome measures 
 
  
 
All Enrolled Patients 
(N=23)                                                                                    
Patients who Completed Outcome 
Measures (N=20) 
  Baseline Baseline  Follow up  
 Mean SD Mean SD Mean SD 
PHQ-15a 15.83 (4.46) 15.80 (4.72) 12.95 (6.45) 
EQ5D-5L Indexb  0.49 (0.26) 0.51 (0.25) 0.48 (0.30) 
EQ5D-5L Health Today c   53.57 (16.46) 54.10 (17.34) 61.35 (25.33) 
PHQ-9 d 10.22 (6.03) 9.85 (5.52) 8.95 (6.94) 
GAD-7 e 7.13 (5.83) 6.55 (5.47) 5.05 (5.62) 
a
 Patient Health Questionnaire-15 measure of symptom severity 
b
 EuroQol 5 Dimensions 5 Levels measure of health-related quality of life 
c
 EuroQol 5-Dimensions 5Levels visual analogue scale of perceived heath 
d
 Patient Health Questionaire-9 measure of depressive symptoms 
e 
Generalised Anxiety Disorder Questionnaire-7  
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Figure 2, Mean time in minutes allocated to intervention components in 
the initial consultations and during total follow up consultations per 
patient  
Initial Consultation 
Follow up Consultations 
*  Learning is included with Explanation and Action rather than reported separately 
** Manage refers to discussion of specific actions to manage symptoms; Challenge refers 
to addressing patient's unhelpful thoughts/attitudes/beliefs about their symptoms 
***Non-core components, e.g. study description, consultation admin, social chit-chat 
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Table 3, Example quotations from follow up patient interviews (with commentary) grouped by 
component of the Symptoms Clinic Intervention 
Example Quotations Comments 
Recognition  
I'd found someone who actually listened to me, it was Dr F obviously, 
and she's very helpful and she seemed to understand what I was talking 
about ... she seemed to understand what was going on. P614 
Because you get that extra time to express yourself, somebody 
genuinely wants to listen to help you that you don't usually feel that 
often from GP appointments, and yeah, you tend to get to the root of 
the problem and the cause.  I would definitely recommend it. P423 
I thought that it was really good.  I thought it really, really helped just 
sort of being able to talk over everything and having someone that bit 
more trained in sort of long term conditions, like, who actually knew 
sort of more in depth what they were talking about. P143 
Participants used emphatic 
speech to describe the doctor 
listening (e.g. “genuinely wants 
to listen”). They described 
feeling understood by the 
doctor, and in the third example 
particularly, the understanding 
appears to include medical 
understanding of the condition 
as well as empathic 
understanding of the patient’s 
predicament. 
Explanation  
… if you don't know what fibromyalgia is and why it's occurring and all 
the different aspects of it, you wonder what the heck's happening to 
you, so if you can get somebody to say 'well that's because of that' I 
think it helps you deal with the problem.  It's always better to know 
what you're dealing with. P606 
Because, as I say, it gave me an insight, a more understanding in what 
was going on with my body and what the outcome is likely to be, [the 
relaxation technique suggested by GP] is sort of... not necessary but it 
helps you, you know, even just the understanding of what's going on is 
mind settling.P614 
I think I had already quite a good understanding of my conditions and 
the symptoms that I have.  I really didn't feel that I got anything new in 
that respect.  I understood the concept of the clinic and I understood 
where the rationale was coming from, but I didn't feel that it 
particularly met my own symptoms and conditions. P418 
 
Participants described 
explanation as providing new 
information which they 
integrated with information they 
already held. Information was 
described as having a purpose 
beyond knowledge – either 
helping deal with a problem or 
rationalising symptom control 
techniques. 
  
Some patients felt they did not 
gain new knowledge and were 
not helped. 
Action & Learning  
‘cause it's certainly helped me … the fact that you can actually do it 
yourself as well by breathing and doing your muscle relaxation, some 
people might think 'oh no it doesn't work', it does, but you have to be 
able to remember that it's there and you're responsible for it.  It's not 
just going to be a sudden quick fix like a pill or something like that, it 
does take time to get used to breathing and then the muscle relaxation 
things, but the more you do it the more automatic it seems to become. 
P126 
Well, I think it's more about anxiety and getting out and about and 
trying to exercise more.  I didn't find overall that it was terrible helpful 
in that way except that it has led to other things whereby I can move 
forward I hope. P145 
Well that's what I'm saying... how could I put it... I don't know, I felt as if 
Dr D was maybe thinking I was getting a bit lazy or something like that, 
you know, which definitely I'm not that type of person, I'm not a lazy 
person, you know, I felt quite uncomfortable with that.  He never 
actually said that, you know what I mean, but I just felt that within 
Behaviour changes were typically 
described as incremental and 
modest. Positive accounts 
included elements of learning 
(e.g. applying a technique for 
one situation in another) or of 
reward through perseverance.  
More neutral accounts were 
constructed in a way which 
acknowledged the possibility of 
benefit while avoiding self-
blame. 
This negative account indicates 
that the patient perceived blame 
in the GP’s approach. 
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myself, you know. P429 
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Highlights 
 
 Experienced GPs were trained to deliver the Symptoms Clinic Intervention to patients  
 This developmental study assessed fidelity, safety and acceptability of delivery 
 The recognition component received most time, explanation and action received less. 
 Patients who benefitted most described receiving all three components. 
